A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
A top US regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
TipRanks on MSN
Tenaya Therapeutics Advances Gene Therapy Study for ARVC
Tenaya Therapeutics, Inc. (($TNYA)) announced an update on their ongoing clinical study. Tenaya Therapeutics, Inc. is conducting a pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback